[Form 4] EverQuote, Inc. Insider Trading Activity

Rhea-AI Filing Summary

EverQuote, Inc. (EVER) director John L. Shields reported a sale of 2,000 shares of Class A common stock on 09/05/2025 at $24.00 per share, leaving him with 29,219 shares beneficially owned. The Form 4 discloses the transaction as a direct sale and is signed by an attorney-in-fact on behalf of the reporting person.

Positive

• Disclosure compliance: The filing clearly reports the transaction details and remaining beneficial ownership
• No derivatives reported: Table II shows no derivative transactions, simplifying ownership picture

Negative

• Insider sale: A director sold 2,000 Class A shares at $24.00, reducing holdings to 29,219 shares

Insights

Securities Analyst

TL;DR: A small, routine director sale reducing holdings to 29,219 shares; not clearly material to valuation.

The Form 4 shows a single, direct sale of 2,000 Class A shares at $24.00 each by a company director. For a public company, this level of insider selling is generally routine and does not by itself indicate a material change in corporate outlook unless it is part of a larger pattern. No derivative transactions or other related-party transfers are reported, and the filing does not provide any explanation for the sale.

Corporate Governance Expert

TL;DR: Director sold a modest number of shares; disclosure is proper and limited in investor impact.

The disclosure satisfies Section 16 reporting requirements by identifying the director, the class of security, the quantity sold, price per share, and remaining beneficial ownership. There are no indications of related compensatory grants or 10b5-1 plan notation in the form. From a governance perspective, this is a standard insider transaction with no additional governance concerns evident in the filing.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Shields John L.

(Last) (First) (Middle)

C/O EVERQUOTE, INC.

141 PORTLAND STREET

(Street)

CAMBRIDGE MA 02139

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
EverQuote, Inc. [ EVER ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/05/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	09/05/2025		S		2,000	D	$24	29,219	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Jon Ayotte, as attorney-in-fact for John Shields	09/09/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did EverQuote (EVER) director John L. Shields report?

He reported a direct sale of 2,000 Class A shares on 09/05/2025 at $24.00 per share.

How many EverQuote shares does John L. Shields own after the sale?

Following the reported sale, he beneficially owns 29,219 shares of Class A common stock.

Was the Form 4 signed and who signed it for John L. Shields?

The form is signed by Jon Ayotte as attorney-in-fact for John Shields.

Does the filing report any options, warrants, or other derivative securities for John Shields?

No. Table II for derivative securities contains no reported transactions or holdings.

Is there any indication this sale was made under a 10b5-1 plan?

The Form 4 does not indicate that the transaction was made pursuant to a 10b5-1 plan.